You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Clinical Trials Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration: Year 1 Results of the FOCUS Study
Jeffrey S. Heier; David S. Boyer; Thomas A. Ciulla; Philip J. Ferrone; J. Michael Jumper; Ronald C. Gentile; Debbi Kotlovker; Carol Y. Chung; Robert Y. Kim; for the FOCUS Study Group
Arch Ophthalmol 2006; 124: 1532-1542.
[Abstract][Full text][PDF]
Clinical Sciences 24-Hour Control With a Latanoprost-Timolol Fixed Combination vs Timolol Alone
Anastasios G. P. Konstas; Symeon Lake; Athanasios I. Economou; Kostantinos Kaltsos; Jessica N. Jenkins; William C. Stewart
Arch Ophthalmol 2006; 124: 1553-1557.
[Abstract][Full text][PDF]
Correspondence Effects of Intravitreous Injection of Preserved and Nonpreserved Triamcinolone in Rabbit Retina—Reply
Dustin Dierks; Bo Lei; Keqing Zhang; Dean P. Hainsworth
Arch Ophthalmol 2006; 124: 1666-a-1668-a.
[Extract][Full text][PDF]
Correspondence Effects of Intravitreous Injection of Preserved and Nonpreserved Triamcinolone in Rabbit Retina
Petros E. Carvounis; Muhammad Abd El Barr; Thomas A. Albini; Eric R. Holz
Arch Ophthalmol 2006; 124: 1666.
[Extract][Full text][PDF]
Socioeconomics and Health Services Effect of Medical Therapy on Glaucoma Filtration Surgery Rates in Ontario
Rony Rachmiel; Graham E. Trope; Mary L. Chipman; Pieter Gouws; Yvonne M. Buys
Arch Ophthalmol 2006; 124: 1472-1477.
[Abstract][Full text][PDF]
Editorials What We Don't Know About Avastin Might Hurt Us
Clinical Trials Twice-Daily 0.2% Brimonidine–0.5% Timolol Fixed-Combination Therapy vs Monotherapy With Timolol or Brimonidine in Patients With Glaucoma or Ocular Hypertension: A 12-Month Randomized Trial
Mark B. Sherwood; E. Randy Craven; Connie Chou; Harvey B. DuBiner; Amy L. Batoosingh; Rhett M. Schiffman; Scott M. Whitcup; for the Combigan Study Groups I and II
Arch Ophthalmol 2006; 124: 1230-1238.
[Abstract][Full text][PDF]
Clinical Sciences Idiopathic Sclerosing Orbital Inflammation
James D. Hsuan; Dinesh Selva; Alan A. McNab; Timothy J. Sullivan; Peerooz Saeed; Brett A. O’Donnell
Arch Ophthalmol 2006; 124: 1244-1250.
[Abstract][Full text][PDF]
Clinical Sciences Short-term Treatment of Cocaine and/or Methamphetamine Abuse With Vigabatrin: Ocular Safety Pilot Results
Robert D. Fechtner; Albert S. Khouri; Emilia Figueroa; Marina Ramirez; Martha Federico; Stephen L. Dewey; Jonathan D. Brodie
Arch Ophthalmol 2006; 124: 1257-1262.
[Abstract][Full text][PDF]
